You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

1608 Results
Document
Jun 2023
Document
Jun 2023
Document
Jun 2023
Drug
Other Name(s): Rylaze™
Quick Link(s): Drug Monograph, Patient Info Sheet
Jan 2024
Guidelines and Advice
Status: Current
ID: GL-END-C50-35
Aug 2023
Document
Dec 2023
Document
Dec 2023
Document
Dec 2023
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    dexamethasone
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
carfilzomib (Unfunded),
dexamethasone,
selinexor (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2024
Document
Jan 2024
Guidelines and Advice
Status: Current
Version: 1.0
Jan 2024
Document
Feb 2024

Pages